Return to Main Menu
|
Garlic compounds may kill brain
cancer cells
by Mary Helen
Yarborough
Public
Relations
The pungent garlic clove used in cooking also could possess a cure for
certain difficult-to-treat brain cancers, according to MUSC researchers.
MUSC received a $1 million grant to study garlic’s effectiveness in
treating glioblastoma, a type of brain tumor equivalent to a death
sentence within a short period after diagnosis. Studies have involved
brain cancer cells from animal models as researchers try to determine
the best pathway to the brain.
Garlic’s cancer-fighting agent is its rich organo-sulfur compound
properties. Garlic already had been proven effective in treating colon,
stomach and prostate cancers, said Swapan Ray, Ph.D., principal
investigator of the MUSC study. Lab tests demonstrated that the
compounds inhibit growth of the brain cancer tumor. “It showed dramatic
shrinking of the tumor,” Ray said.
Ray, a Neurosciences/Neurology associate professor, is working with
fellow department professor Naren Banik, Ph.D., and postdoctoral fellow
Arabinda Das, Ph.D. They have studied three pure organo-sulfur
compounds (DAS, DADS, and DATS) from garlic and the interaction each
had with human glioblastoma cells. All three compounds demonstrated
efficacy in eradicating brain cancer cells, but DATS (with three sulfur
atoms) proved to be the most effective, lending more support to
previous studies of that particular compound. The study will be
published in the September issue of Cancer, which is the premier
journal of the American Cancer Society.
Cancer cells are known to have an incredibly high metabolism, as they
require much energy to divide cells for rapid growth. In this study, it
has been shown that garlic compounds produce reactive oxygen species in
rapidly growing brain cancer cells, essentially gorging them to death
with activation of multiple death cascades.
“This research highlights the great promise of plant-originated
com-pounds as natural medicine for controlling the malignant growth of
human brain tumor cells,” Ray said. “However, more studies are needed
in animal models of brain tumors before application of this therapeutic
strategy to brain tumor patients.”
Banik is enthusiastic about this discovery, which actually emerged as a
side study from another project.
“Our basic studies will eventually be translated to the clinics for
patient care. Although we may have to wait several years before its
application to humans, the significance of this discovery is enormous,”
Banik said. “The benefits from this research to brain cancer patients
will bring great satisfaction to the researchers and clinicians who are
now trying to find a successful treatment for this devastating cancer.”
Future research will include animal studies prior to clinical trials,
Ray said.
While it is unlikely that eating garlic cloves would have any
significant affect on brain cancer, eating garlic has a number of
healthful affects, including reduced blood pressure as well as heading
off other cancers in the digestive tract.
Because garlic-derived organo-sulfur compounds are small molecules,
they may not require complicated methods of vascular delivery for
treating brain tumor patients. And by virtue of their natural origin,
the garlic compounds are probably better for the human body than
synthetic treatment options, Ray said.
Ray has already received two R01 grants (combined funding of
approximately $2.5 million), one from the National Cancer Institute and
another from the National Institute of Neurological Diseases and
Stroke, to support his neuro-oncology research program. He has a
productive research team that includes five post-doctoral fellows.
As for those who desire any potential anti-cancer benefits from garlic
now, certain rules apply. Ray said people should cut and peel a piece
of fresh garlic and let it sit for 15 minutes before eating or cooking
it. This amount of time is needed to release an enzyme (allinase) that
produces these anti-cancer compounds. Both Ray and Banik caution the
public against eating too much garlic, noting that too much of it can
cause diarrhea, allergies, internal bleeding, bad breath and body odor.
Friday, Aug. 31, 2007
Catalyst Online is published weekly,
updated
as needed and improved from time to time by the MUSC Office of Public
Relations
for the faculty, employees and students of the Medical University of
South
Carolina. Catalyst Online editor, Kim Draughn, can be reached at
792-4107
or by email, catalyst@musc.edu. Editorial copy can be submitted to
Catalyst
Online and to The Catalyst in print by fax, 792-6723, or by email to
catalyst@musc.edu. To place an ad in The Catalyst hardcopy, call Island
Publications at 849-1778, ext. 201.
|